Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.3K
Overview
44.3K
Development of Immunocompetence01:22

Development of Immunocompetence

1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Vaccine Production01:23

Vaccine Production

152
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
152
Vaccines01:21

Vaccines

104
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
104

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful vaccination for Lyme disease: a novel mechanism.

Expert opinion on investigational drugs·2005
Same author

Safety and immunogenicity profile of a recombinant outer-surface protein A Lyme disease vaccine: clinical trial of a 3-dose schedule at 0, 1, and 2 months.

Clinical therapeutics·2000
Same author

Differential expression of Borrelia burgdorferi genes during erythema migrans and Lyme arthritis.

The Journal of infectious diseases·1998
Same author

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group.

The New England journal of medicine·1998
Same author

Immunizations for international travelers.

The Western journal of medicine·1998
Same author

The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study.

Annals of internal medicine·1998

Related Experiment Video

Updated: May 5, 2026

Feeding of Ticks on Animals for Transmission and Xenodiagnosis in Lyme Disease Research
08:23

Feeding of Ticks on Animals for Transmission and Xenodiagnosis in Lyme Disease Research

Published on: September 1, 2013

12.8K

The Lyme disease vaccine: conception, development, and implementation.

W T Thanassi1, R T Schoen

  • 1Section of Emergency Medicine, Yale University School of Medicine, New Haven, Connecticut 06519, USA.

Annals of Internal Medicine
|April 15, 2000
PubMed
Summary
This summary is machine-generated.

A novel Lyme disease vaccine (LYMErix) was approved in 1998. This vaccine targets Borrelia burgdorferi, reducing human infection by working within the tick vector.

More Related Videos

Detecting the Lyme Disease Spirochete, Borrelia Burgdorferi, in Ticks Using Nested PCR
07:20

Detecting the Lyme Disease Spirochete, Borrelia Burgdorferi, in Ticks Using Nested PCR

Published on: February 4, 2018

21.9K
Phage-Mediated Genetic Manipulation of the Lyme Disease Spirochete Borrelia burgdorferi
09:01

Phage-Mediated Genetic Manipulation of the Lyme Disease Spirochete Borrelia burgdorferi

Published on: September 28, 2022

2.5K

Related Experiment Videos

Last Updated: May 5, 2026

Feeding of Ticks on Animals for Transmission and Xenodiagnosis in Lyme Disease Research
08:23

Feeding of Ticks on Animals for Transmission and Xenodiagnosis in Lyme Disease Research

Published on: September 1, 2013

12.8K
Detecting the Lyme Disease Spirochete, Borrelia Burgdorferi, in Ticks Using Nested PCR
07:20

Detecting the Lyme Disease Spirochete, Borrelia Burgdorferi, in Ticks Using Nested PCR

Published on: February 4, 2018

21.9K
Phage-Mediated Genetic Manipulation of the Lyme Disease Spirochete Borrelia burgdorferi
09:01

Phage-Mediated Genetic Manipulation of the Lyme Disease Spirochete Borrelia burgdorferi

Published on: September 28, 2022

2.5K

Area of Science:

  • Medical Entomology
  • Vaccinology
  • Infectious Diseases

Background:

  • Lyme disease is a significant public health concern caused by Borrelia burgdorferi.
  • Preventing human infection requires targeting the tick vector or the pathogen.
  • Recent advancements have focused on novel vaccine strategies.

Purpose of the Study:

  • To introduce the development and approval of a recombinant outer surface protein A vaccine against Lyme disease.
  • To highlight the unique mechanism of action of this vaccine.
  • To underscore its potential impact on reducing Lyme disease morbidity and costs.

Main Methods:

  • Development of a recombinant outer surface protein A (OspA) vaccine.
  • The vaccine is derived from Borrelia burgdorferi, the causative agent of Lyme disease.
  • The vaccine targets the spirochete within the tick vector.

Main Results:

  • The U.S. Food and Drug Administration approved the Lyme disease vaccine (LYMErix) in December 1998.
  • The vaccine's mechanism prevents Borrelia burgdorferi from infecting humans by acting within the tick.
  • This approach offers a novel strategy for Lyme disease prevention.

Conclusions:

  • The LYMErix vaccine represents a significant advancement in preventing Lyme disease.
  • Its unique mechanism of action within the tick vector holds promise for reducing disease burden.
  • Further understanding of vector-targeted vaccines can inform future public health strategies.